Michael Berelowitz - Director, Oramed Pharmaceuticals Inc

As of December 10, 2015


Michael Berelowitz Net Worth

  • Net worth is estimated to be at least $726.91K
  • Owns at least 22,896 units of Oramed Pharmaceuticals Inc stock
  • Sold an estimated value of $116.97K in the last year at Oramed Pharmaceuticals Inc

Michael Berelowitz Trading

  • Largest purchase of shares was 9,434 units , worth over $48.74K on April 2, 2014
  • Largest sale of shares was 9,434 units , worth over $99.06K on April 2, 2014
  • In total has made about 6 transactions over a year
  • Usually trades in April and December, with the busiest year in 2015 and 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Michael Berelowitz Mailing Address

  • Mailing address is 415 East 37th Street Apt 36c New York NY 10016 NY

Oramed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Nadav Kidron 2020 $439,076 $220,582 $569,062 $539,131 $1,767,851
Nadav Kidron 2019 $419,460 $224,975 $398,910 $507,750 $1,551,095
Nadav Kidron 2018 $436,310 $148,795 $522,569 $442,326 $1,550,000
Miriam Kidron 2020 $305,840 $70,000 $299,506 $13,354 $688,700
Miriam Kidron 2019 $267,386 $123,149 $211,128 $14,503 $616,166
Miriam Kidron 2018 $273,595 $46,614 $253,204 $13,643 $587,056
Avraham Gabay 2020 $130,554 $15,591 - $44,912 $191,418
Avraham Gabay 2019 $32,122 - $73,928 $9,441 $115,491
Joshua Hexter 2020 $190,801 $12,169 $351,128 $54,735 $608,833
Joshua Hexter 2019 $52,848 - - $9,022 $61,870
Joshua Hexter 2018 $161,002 $26,895 $269,196 $50,505 $507,598
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm

Oramed Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 21,100 units sold on September 20, 2021 by Kevin Rakin worth over $442.83K
  • In the last 13 years, insiders at Oramed Pharmaceuticals Inc sold an estimated value of $10.81M and bought an estimated value of $6.08M
  • The most active traders are Miriam Kidron, Chief Scientific Officer,  Leonard Sank, Director,  and Nadav Kidron, President and CEO
  • Insider trading is most common in February, with the busiest year in 2014

ORAMED PHARMACEUTICALS INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1